I
IRRA
vs
J
Jakarta Composite Index
Over the past 12 months, IRRA has underperformed Jakarta Composite Index, delivering a return of +2% compared to the Jakarta Composite Index's +19% growth.
Stocks Performance
IRRA vs Jakarta Composite Index
Performance Gap
IRRA vs Jakarta Composite Index
Performance By Year
IRRA vs Jakarta Composite Index
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Itama Ranoraya PT
Glance View
PT Itama Ranoraya Tbk operates as a medical devices distributor. The company is headquartered in Jakarta Timur, Dki Jakarta and currently employs 169 full-time employees. The company went IPO on 2019-10-15. The firm operates in the field of wholesale trading of laboratory equipment, pharmaceutical equipment, and medical devices for humans. The firm carries out its operations through four products, namely the non-electromedical sterile medical devices, in-vitro diagnostic, electromedical sterile medical devices, and other products. Its business segment focuses on in-vitro diagnostic (IVD), medical imaging, surgical instrument and disposable, critical care, blood banking and transfusion, cardiovascular, brain management, cancer, urology, and maternal and neonatal care. Its products include Oneject, Abbott, Terumo, Becton Dickinson (BD), HMD, Vestfrost, Balmed, iGene, AVIMAC, and HemoCue.
